Literature DB >> 3677287

Anaesthetic management of patients with placenta accreta.

A A Kamani1, D R Gambling, J Christilaw, M L Flanagan.   

Abstract

The management of a 28-year-old primigravida with placenta accreta diagnosed during Caesarean section is described. A hysterectomy was required to control massive haemorrhage, and the patient made a full recovery. The increased incidence of placenta accreta over the last three decades is thought to be associated with the concomitant increased frequency of Caesarean section, resulting in an increased incidence of placenta praevia (1.9 per cent to 3.9 per cent). Patients with placenta praevia who have had a previous Caesarean section have a remarkably increased risk of placenta accreta. Management of placenta accreta is primarily by control of haemorrhage on delivery of the placenta. Control can be assisted by infrarenal cross-clamping of the aorta and/or intra-myometrial injection of prostaglandin F2 alpha which produces myometrial and vascular contraction. Identification of patients at increased risk, preparation for treatment and effective treatment of placenta accreta will minimize maternal morbidity and mortality.

Entities:  

Mesh:

Year:  1987        PMID: 3677287     DOI: 10.1007/BF03010522

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  13 in total

1.  Placenta accreta; an analysis based on an unusual case.

Authors:  B MEYER
Journal:  Acta Obstet Gynecol Scand       Date:  1955       Impact factor: 3.636

2.  Cardiovascular and respiratory responses to intravenous infusion of prostaglandin F 2 in the pregnant woman.

Authors:  J I Fishburne; W E Brenner; J T Braaksma; L G Staurovsky; R A Mueller; J L Hoffer; C H Hendricks
Journal:  Am J Obstet Gynecol       Date:  1972-11-15       Impact factor: 8.661

3.  Physiology of internal iliac artery ligation.

Authors:  R C Burchell
Journal:  J Obstet Gynaecol Br Commonw       Date:  1968-06

4.  Placenta accreta. A 26-year clinicopathologic review (1956--1981).

Authors:  L Hutton; S S Yang; J Bernstein
Journal:  N Y State J Med       Date:  1983-05

5.  Placenta accreta, percreta and praevia accreta.

Authors:  D H Kitchen
Journal:  Aust N Z J Obstet Gynaecol       Date:  1978-11       Impact factor: 2.100

6.  The effects of intramyometrial injection of prostaglandin F2alpha on severe post-partum hemorrhage.

Authors:  S Takagi; T Yoshida; Y Togo; H Tochigi; M Abe; H Sakata; T K Fujii; H Takahashi; B Tochigi
Journal:  Prostaglandins       Date:  1976-10

7.  Placenta previa/accreta and prior cesarean section.

Authors:  S L Clark; P P Koonings; J P Phelan
Journal:  Obstet Gynecol       Date:  1985-07       Impact factor: 7.661

8.  Control of postpartum uterine atony by intramyometrial prostaglandin.

Authors:  S L Bruce; R H Paul; J P Van Dorsten
Journal:  Obstet Gynecol       Date:  1982-06       Impact factor: 7.661

9.  Placenta accreta: changing clinical aspects and outcome.

Authors:  J A Read; D B Cotton; F C Miller
Journal:  Obstet Gynecol       Date:  1980-07       Impact factor: 7.661

10.  Intramyometrial prostaglandin F2 alpha in the treatment of severe postpartum hemorrhage.

Authors:  M M Jacobs; F Arias
Journal:  Obstet Gynecol       Date:  1980-05       Impact factor: 7.661

View more
  2 in total

1.  Anaesthesia for caesarean hysterectomy in a patient with a preoperative diagnosis of placenta percreta with invasion of the urinary bladder.

Authors:  T Hunter; S Kleiman
Journal:  Can J Anaesth       Date:  1996-03       Impact factor: 5.063

2.  Cardiovascular collapse following an overdose of prostaglandin F2 alpha: a case report.

Authors:  M J Douglas; D F Farquharson; P L Ross; J E Renwick
Journal:  Can J Anaesth       Date:  1989-07       Impact factor: 5.063

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.